Replies to post #213225 on Biotech Values

[linhdtu]

Dew, I have seen this movie before with Novo and GBT.

https://www.streetinsider.com/Hot+M+and+A/Novo+Nordisk+%28NVO%29+in+Bid+for+Global+Blood+Therapeutics+%28GBT%29+-+Reuters/12645390.html

my objection to the BS at the time was that gbt P3 won't see headlines till YR17. It is too early for a fair price to be agreed between the parties.

and the same argument holds today. there is no approval for oma yet. How much would a buyer willing to pay ? and if prtk is so eager to sell before approval, how much confidence they have in their own data and if I am a buyer I would be asking the same question lol.

nevertheless mr mkt behavior is rather comfortingly predictable to me !!